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Summary 
As ancestral haplotypes of the major histocompatibility complex (MHC) appear to define identical 
MHC haplotypes in unrelated individuals, unrelated individuals sharing the same ancestral haplotype 
should also share the same NK-defined allospecificities  that have recently been shown to map 
to the human MHC. To test this prediction, multiple cell lines from unrelated individuals sharing 
the same ancestral haplotypes were tested for the NK-defined allospecificities.  It was found that 
cells sharing the same ancestral haplotypes do have the same NK-defmed specificities. Furthermore, 
the NK-defined phenotype of ceUs that possess two different ancestral haplotypes can be predicted 
from the NK-defined phenotypes of unrelated cells that are homozygous for the ancestral haplotypes 
concerned. Although the group 1 and 2 NK-defined allospecificities  can be explained to some 
extent by HLA-C alleles, evidence is presented that additional genes may modify the phenotype 
conferred by HLA-C. 
W 
'ith the expanding use of bone marrow transplanta- 
tion  there is an increasing number of patients  for 
whom an HLA genotypically identical sibling donor is not 
available. Unrelated donors identified from large panels are 
being used. Current strategies for donor/recipient matching 
require detailed matching for alleles at HLA class I and II 
loci. It is evident that these approaches are inadequate (1). 
Graft rejection can occur despite apparently good matching 
whereas successful outcome can occur despite mismatches at 
these loci  (2).  Current  methods may not  allow  adequate 
matching of the class I and II alleles. This has been demon- 
strated in a case report  of T  cell rejection involving mis- 
matching at HLA-B (3).  In addition, however, other poly- 
morphic non-HLA genes within the MHC may be involved, 
and matching for HLA alone does not ensure matching for 
these genes. There is direct evidence in the mouse for the 
presence of at least one set of such genes. 
The hemopoietic histocompatibility (Hh) 1 system in mice 
has been shown to determine F1 hybrid resistance to a bone 
marrow graft from either parent with graft rejection medi- 
1 Abbreviations used in this~per: AH, ancestral haplotype; Hh, hemopoietic 
histocompatibility; LCL, lymphoblastoid cell line. 
ated by radio-resistant NK cells (for a review see reference 
4). Unlike the classical MHC antigens, the Hh antigens are 
inherited in a recessive fashion (5). It has been suggested that 
the major Hh locus (Hh-1) maps within the H-2 complex 
between H2-S and H2-D  and can be dissociated from the 
class I genes (6, 7). However, the class I MHC antigens may 
play a role in the function or expression of Hh-1 antigens 
(for a review see reference 8). One model suggests two genetic 
loci Hh-lr and Hh-ls control expression of Hh-1 antigens. 
The Hh-ls genes encode the structural antigen whereas the 
Hh-lr gene downregulates expression of the Hh-ls genes. 
Complex Hh-1 haplotypes have been suggested (8). Com- 
patibility between the donor and recipient at Hh-1 is required 
to prevent NK-mediated graft rejection. 
There is now good evidence that the equivalent of the Hh-1 
system exists  in humans.  In a series of papers,  Ciccone et 
al. (9) have demonstrated that NK cells can mediate specific 
allogeneic target cell lysis.  NK clones derived from single 
donors can recognize different allospecificities  (10) and five 
different allospecificities have been defined (11). Susceptibility 
to lysis by NK clones recognizing specificities  1,  2,  and 3 
and probably 4 and 5 has been shown to be inherited in an 
autosomal  recessive  manner whereas resistance  to  lysis  is 
dominantly inherited (11). Segregation studies and mapping 
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the genes controlling susceptibility or resistance to lysis are 
localized within the MHC between complement factor Bf 
and the HLA-A locus (12). The nature of the target mole- 
cules is uncertain. However, in a recent series of studies, Cic- 
cone et al. have provided evidence that HLA-Cw3 can pro- 
vide specific protection of target cells against lysis mediated 
by group 2-reactive NK clones (13) and the group 1 and 2 
specificities are reciprocally associated with homozygosity  for 
a diallelic polymorphism at amino acid positions 77 and 80 
on HLA-C (14). 
Given the existence of the human equivalent of Hh-1, it 
is likely that NK allorecognition is involved in human bone 
marrow graft rejection. Therefore, simple means of matching 
for these determinants and to retrospectively analyze cases 
for such matching are required. 
We have previously shown that the polymorphism of the 
human MHC can be described in terms of a limited number 
of ancestral  haplotypes (AH) and their recombinants (15). 
Increasingly it is evident that these AH have been maintained 
en bloc from remote ancestors and that each haplotype defines 
a continuous specific sequence of DNA (16-18).  It follows, 
therefore, that AH provide markers for alleles at unknown 
as well as known genes in the MHC. We therefore predicted 
that each AH would be associated with particular sets of NK- 
defined determinants (NK haplotypes). Consequently, the 
identification of AH would provide an effective means of 
matching for the NK-defined specificities before bone marrow 
transplantation. Therefore in this study we determined the 
NK-defined specificities present on target cells carrying var- 
ious AH and related the findings to the known alleles present 
on these haplotypes. 
Materials and Methods 
Target Cells for  NK  Allorecognition.  A  panel of 34  EBV- 
transformed  lymphobhstoid cell  lines 0./ZLs)  served  as targets. These 
cells were selected from an extensive  local panel of LCLs based on 
being either homozygous or heterozygous for the ancestral haplo- 
types listed in Table 1. Several of these cells were included in the 
10th International Histocompatibility Workshop cell panel held 
in Princeton, NJ and New York, NY, 12-23 November 1987. Each 
cell has been characterized using all the MHC markers listed in 
Table 1 to confirm the presence of the particular AH. HLA-A, -B, 
-C and DR, DQ serological  typing was performed  by a complement- 
mediated microcytotoxicity assay using a panel of antisera exten- 
sively characterized against standard cells included in previous In- 
ternational Histocompatibility Workshops. DNA-based HLA class 
II typing was performed according to the methods detailed in the 
11th International  Histocompatibillty  Workshop held in Yokohama, 
Japan, 6-13 November 1991 using a series of sequence-specific  oli- 
gonucleotide probes labeled with derivatised horseradish peroxi- 
dase suitable for detection by enhanced chemiluminescence (19). 
Complement components C4 and Bf aUotyping  was performed by 
immunofixation using appropriate antisera after electrophoresis as 
described previously (20). Methods for the typing of the alleles at 
TNF (21), BAT3 (22), and XYV (19) have  been described  previously. 
Isolation of  NK-clones and Evaluation of  Ng Cytotoxicity.  NK al- 
loreactivity against the LCL target cells was evaluated  using previ- 
ously described methods (11). In brief, PBL from normal donors 
were isolated on Ficoll-Hypaque gradients and NK cells enriched 
after depletion of T cells using a mixture of mAbs against CD3, 
CD4, and CD8 (9, 10). The viable cells were then separated on 
a Ficoll-Hypaque gradient. These viable NK-enriched cells were 
then cloned under limiting dilution conditions in the presence of 
irradiated feeder  cells, 0.1% PHA and recombinant IL-2. The NK- 
defined  specificities  present on the LCL target cells were determined 
in a 4-h nCr-release assay  using cloned NK effector cells reacting 
specifically  with group I (ES2 or ES10), group 2 (AM25, Mauro 
P), group 3 (A51-8), and group 5 (OA64) specificities.  Target cells 
were used at 5  x  103/well, for a final E/T ratio of 10:1. Percent 
specific lysis was determined as described previously (9,  10). 
Using this assay  cytotoxicity is usually clearly bimodal. Target 
cells considered negative for a specificity  give ~10% lysis whereas 
targets considered positive give >20% lysis with the specific NK 
clone (11). 
HLA-C Alleles and Sequencing.  All target cells  were HLA typed 
for the presence of the Cw alleles 1-7. The Cw allele associated 
with each AH has been previously established based on typing of 
many examples of each AH. The presence of the amino acids at 
residues 77 and 80 on the c~ chain of the Cw molecule present 
on each AH was established  by review of published nucleotide se- 
quences (23) and for Cw4 from a sequence submitted to GenBank 
(sequence number M84386) by Dr. P. Parham. This sequence was 
derived from a HLA-B35 positive cell and has therefore been provi- 
sionally assigned to the 35.1 and 35.4 AH. 
The HLA-C allele on the 44.2 AH was sequenced by the fol- 
lowing method. HLA-C was specifically  amplified  by PCR using 
primers and conditions  described  previously  (14). The resulting PCR 
product was diluted I in 25 in distilled water and reamplified  with 
nested degenerate  primer CACAGAAGTACAA(C/G)CGCCAGG 
(5; nucleotides 189-209, exon 2) and the same 3' primers used in 
the original PCR. The nested PCR was performed in a standard 
PCR reaction, using 25/zl of  diluted product in 50 gl of final reac- 
tion mix, with l-rain steps at 94, 60, and 72~  for 30 cycles  with 
2-s increments  every  cycle.  The resulting PCR product was purified 
by  column  centrifugation  (Centricom  30  microconcentrator; 
Amicon W.R. Grace & Co., Beverly, MA) and sequenced using 
fluorescent labeled  dideoxy termination reactions on an automated 
DNA sequencer (model 373A; Applied Biosystems, Inc., Foster 
City,  CA) with the primers used to produce the  nested PCR 
product. 
Results 
NK Group 1 and 2 Specificities Are Associated with Particular 
AH.  The cytotoxicity  of the NK clones defining the group 
I and 2 specificities against the 34 LCL target cells are shown 
in Table 2. Several points are evident. The specific lysis is bi- 
modal with most target cells dearly positive (>20%  lysis) 
or negative (~<10%). All cells homozygous for an AH ex- 
press either a group 1 or 2 specificity and these specificities 
behave as alleles at a single locus. The results for cells hetero- 
zygous for two AH are predictable from the results obtained 
with the cells that are homozygous for these AH and a reces- 
sive model of susceptibility to lysis. For example,  both the 
8.1 and 7.1 AH carry the group 1 specificity and cells R7/17219 
and Q9/20920  which are heterozygous for these two AH 
are group 1 positive.  On the other hand, cell Q6/8187  is 
heterozygous for AH 8.1 and 57.1 which bear group 1 and 
2 specificities, respectively,  and expresses neither the group 
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for the 44.2 AH gave indeterminate cytotoxicity  of 14% with 
the group 1 clone. This cell has been considered group 1 posi- 
tive. This classification is supported by the results of two other 
cells (K8/5618, Q5/7952) that are heterozygous for 44.2 and 
another AH which is clearly group 1 positive based on the 
results for homozygous cells. Both these cells are group 1 
positive (37 and 27% cytotoxicity, respectively)  indicating 
that the 44.2 AH must also be group 1 positive under a reces- 
sive model of susceptibility to lysis. However the cytotox- 
icity of both these cells and the homozygous cell is lower 
than that present in most of the other group i positive cells. 
These data suggest that the Cw allele present on the 44.2 
AH is different from the other Group  1 alleles. 
The results for the 68 haplotypes present on the 34 cells 
are summarized in Table 3. All AH tested carry either the 
group 1 or 2 specificity. All examples of the same AH from 
unrelated individuals bear the same NK-defined specificity, 
i.e., these specificities are AH haplotypic. Therefore, AH will 
identify the specificity present and the NK-defined pheno- 
type of a cell can be predicted by the AH present. 
NK-defined Haplotypes Occur and Are Associated with Partic- 
ularAH.  Having shown that the group 1 and 2 determinants 
are AH haplotypic, we examined whether more complex NK- 
defined haplotypes are also associated  with particular AH. 
A subset of 12 of the 34 target cells were therefore addition- 
ally tested against NK clones defining the group 3 and 5 
specificities. These included ceils homozygous for the 7.1, 
8.1,  18.2,  60.1,  57.1,  and 44.1 AH and three heterozygous 
cells. All 12 cells were positive for the group 3 specificity 
so the nature of the group 3 inheritance could not be deter- 
mined. The 7.1, 8.1, and 44.1 homozygous cells were all posi- 
tive and the 18.2 and 57.1 homozygous cells were negative 
for the group 5 specificity. However, the results in the three 
heterozygous cells cannot simply be explained by the same 
genetic model as the group  1 and 2 specificities. 
From the results obtained above, several points are evident: 
(a) target cells homozygous for an AH can encode several 
specificities;  (b)  sets  of NK-defined specificities  (i.e.,  NK- 
defined haplotypes) occur; (c) unrelated individuals homozy- 
gous for the same AH express the same NK-defined haplo- 
type, i.e., NK-defined haplotypes are AH haplotypic; and (d) 
the same NK-defined haplotype can be shared between sev- 
eral different AH. 
Residues 77-80 on the HLA-C Molecule Do Not Account  for 
All NK-defined Specificities.  Having demonstrated that NK 
specificities  associate  with particular AH,  we determined 
whether these associations could be accounted for by the two 
alternate epitopes at amino acid residues 77 and 80 on HLA-C 
associated with the group 1 and 2 specificities (13, 14). There- 
Table  1.  List of MHC Ancestral Haplotypes Included in this Study 
MHC alleles and KFLP markers 
Name  A  Cw  B  Ya  Yb  X  V  TNF  B144  BAT3  C2  Bf C4A  C4B  DR  DRB1  DBK3  DRB4  DRB5  DQA1  DQw  DQB1 
7.1  3  7  7  A  S  L  A  L  S  L  C  S  3  1  15  1501  0101  0102  6  0602 
8.1  1  7  8  B  S  L  B  S  S  S  C  S  Q0  1  3  0301  0101  0501  2  0201 
13.1  30  6  13  D  L  L  C  L  S  C  S  3  1  7  07  0101  0201  2  0201 
18.1  25  18  A  S  S  B  L  S  L  Q0  S  4  2  15  1501  0101  0102  6  0602b 
18.2  30  5  18  C  S  M  A  L  S  S  C  F1  3  Q0  3  0301  0202  0501  2  0201 
18.3  18  L  S  3  1  11  (1102)(0202)  (0501)  7  (0301) 
35.1  4  35  C  S  L  A  S  S  L  S  3  1  11  1104  0202  0501  7  0301 
35.4  4  35  G  L  B  S  L  S  3  1  11  1103  0202  0501  7  0301 
44.1  2  5  44  A  S  L  C  S  S  L  C  S  3  Q0  4  0401  0101  (0301)  7  (0301) 
44.2  29  44  D  L  L  C  L  L  C  F  3  1  7  07  0101  0201  2  0201 
46.1  2  1  46  A  S  L  C  S  L  C  S  4  2  9  0901  (0101)  (0301)  9  (0303) 
52.1  24  52  A  L  A  L  C  S  3+2  Q0  15  1502  (0102)  (0103)  6  (0601) 
54.1  1  54  E  L  M  C  L  S  L  C  S  3  5  4  0405  (0101)  (0301)  4  (0401) 
57.1  1  6  57  E  L  S  C  L  S  L  C  S  6  1  7  07  0101  0201  9  0303 
58.1  33  58  S  S  S  S  S  3  Q0  3  0301  02  (0501)  2  (0201) 
60.1  3  60  S  L  C  S  3  1  4  (0404)  (0101)  (0301)  3  (0302) 
60.3  2  3  60  A  L  B  S  S  C  S  Q0  2  13  1302 (0301)  (0102)  6  (0604) 
62.1  2  3  62  A  L  B  L  S  L  C  S  3  3  4  0401  0101  0301  8  0302 
TNF, B144, and BAT3 determined by KFLP typing. DRB1, DKB3, DRB4, DRBS, DQA1, and DQB1 determined by DNA typing. Ya, probe 
Y/TaqI  +  RsaI; Yb, probe Y/Bst Ell; X, probe X/TaqI; V, probeV/Taql;  S, short fragment; M, medium fragment; L, long fragment; (  ), 
provisional assignment. 
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7.1  85*  10  1 +,  2 - 
7.1  67  5  1+,  2- 
8.1  65  2  1+,  2- 
8.1  90  6  1+,  2- 
46.1  72  4  1 +,  2- 
46.1  75  ND  1,  (2 -  )* 
52.1  44  12  1+,  2- 
52.1  32  2  1 +,  2 - 
54.1  95  ND  1 +,  (2 -)* 
62.1  48  ND  1 +,  (2 -)* 
18.1  65  2  1 +,  2 - 
60.1  61  0  1+,  2- 
60.3  100  5  1 +,  2- 
44.2  14  ND  1 + ,(2 -  )* 
18.2  4  42  1 -,  2 + 
18.2  5  61  1 -,  2 + 
57.1  3  88  1-,  2+ 
44.1  ND  52  1-,  2+ 
13.1  11  54  1-,  2+ 
35.1  2  ND  1 -,  (2 + )s 
35.4  8  ND  1 -,  (2 + )s 
7.1  8.1 
7.1  8.1 
62.1.  8.1 
62.1  8.1 
62.1  7.1 
60.3  44.2 
62.1.  44.2 
46.1  54.1 
60.3.  57.1 
8.1.  57.1 
46.1  13.1 
7.1.  44.1 
7.1.  44.1 
92  10 
70  0 
63  3 
83  ND 
70  ND 
37  0 
27  ND 
63  ND 
0  ND 
5  0 
4  2 
0  ND 
0  0 
1+  2- 
1+  2- 
1+  2- 
1+  (2-)* 
I+  (2-)* 
1+  2- 
1+  (2-)* 
I+  (2-)* 
1-(2-) 
1-  2- 
1-  2- 
1-  (2-) 
1-  2- 
* Results expressed as percent slCr-release. 
* Group 2 negative based on positive reactivity with group  1. 
S Group 2 positive based on negative group  1 reactivity. 
fore, the HLA-C allele and the epitope present on each AH 
was examined. These results are summarized in Table 4.  In 
all cases where data are available, the results fit the hypoth- 
esis that  the alternative epitopes defined at  residues 77-80 
are associated with the NK-defined group I and 2 specificities. 
However the NK specificity associated with the 44.2 AH is 
unusual  in expressing group  1  target relatively weakly. 
In view of the different phenotype of the 44.2 AH,  the 
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with Each Ancestral Haplotype 
AH 
No. of 
haplotypes  Group  1  Group 2 
tested  positive  positive 
7.1  9*  9  0 
8.1  9  9  0 
18.1  2  2  0 
44.2  4  4  0 
46.1  6  6  0 
52.1  4  4  0 
54.1  3  3  0 
60.1  2  2  0 
60.3  4  4  0 
62.1  6  6  0 
13.1  3  0  3 
18.2  4  0  4 
44.1  4  0  4 
57.1  4  0  4 
35.1  2  ND  2* 
35.4  2  ND  2~ 
* Cells homozygous for a single AH were considered to provide two 
examples of the same AH. 
* Based on group 1 reactivity only. 
HLA-C allele  of this cell was sequenced from nucleotides 
190-269 of exon 2,  in the expectation that  this allele  may 
possess a different epitope from those shown to correspond 
to groups 1 and 2. Surprisingly,  this cell carries the S - - N 
epitope expected for group 1 positive cells. However, its se- 
quence apparently describes a new HLA-Cw allele. This new 
allele is identical to Cwl and HLA-Cw*1401 in this region, 
except that  it  has an  "A" at  nucleotide 267. 
It is also evident that  the group 3 and 5 specificities  are 
not associated with any particular  C  allele  or either of the 
two alternative  Cw epitopes at residues 77 and  80. 
Discussion 
In this study we have utilized cells that are homozygous 
or heterozygous for particular AH as target cells for NK dones 
defining specificities 1, 2, 3, and 5. We have shown that all 
ceils homozygous for an AH express either a group 1 or 2 
determinant  and that  the phenotypes of heterozygous cells 
can be predicted from the results in the homozygous cells 
and a recessive model of inheritance for susceptibility to lysis. 
Homozygous cells carry several NK-defined specificities, sug- 
gesting the presence of NK-defined haplotypes. Without ex- 
ception, all examples of the same AH carry the same group 
1 or 2 specificity, and in the more limited panel of cells tested, 
carry the same NK-defined haplotype, i.e.,  the NK-defined 
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specificities  are AH haplotypic. Therefore, the identification 
of AH will  allow the identification  of the associated NK 
specificities  and provide a simple means of identifying the 
presence of these specificities  in an individual.  Based on the 
particular combination of AH present, the NK-defmed pheno- 
type of an individual  can be predicted. 
Whereas AH provide an excellent means of identifying the 
presence of a particular NK-defined haplotype, the relevant 
genes may be encoded anywhere along the haplotype. Else- 
where we have provided evidence that AH consist of several 
blocks of several  hundred  kilobases of DNA.  Recombina- 
tion can occur preferentially between these blocks, but has 
not been observed within them.  In fact, there appear to be 
at least four distinct blocks of polymorphism within the MHC 
interval,  viz. (a) the c~ block which carries HLA-A; (b) the 
3 block which carries HLA-C, HLA-B, and CL (24); (c) the 
3, block which carries complement components C4, C2, and 
Bf and the Cyp21 genes; and (d) the ~ block which carries 
the  DR  and  DQ  gene clusters.  Mapping  studies  in both 
humans  (12) and in mice (6,  7) and examination of several 
cells bearing recombinant AH (data not shown) all suggest 
that the genes encoding the group  1 and 2 NK-defined al- 
lospecificities are  carried on the 3  block. 
The nature of the target  molecules for NK allorecogni- 
tion has  not been determined.  Ciccone et al.  (13) have re- 
cently suggested that HLA class I molecules are directly in- 
volved. HLA-Cw3 provides protection against lysis mediated 
by group 2 reactive clones. This resistance to lysis was in- 
herited in a dominant manner and was specific for the group 
2 specificity.  Two alternative epitopes defined by polymor- 
phism of amino acid residues 77 and 80 on HLA-C have been 
shown to be associated with protection  against  the group 
1 and 2 specificities  (14).  The present data support this hy- 
pothesis, but also show that these epitopes are not associated 
with the group 3 or 5 specificities. HLA-C is included within 
the 3  block.  In all  those cases where data is available,  the 
group 1 and 2-associated AH carry the predicted HLA-Cw 
epitope. However, cytotoxicity by the group 1 reactive NK 
clones against the 44.2 AH homozygous cell is only weak, 
and the two cells heterozygous for this AH gave cytotoxicity 
considerably less than other susceptible cells. We have shown 
that this AH carries a new HLA-C allele which may behave 
similarly to FILA-Cw*1401, as reported by Colonna et al. (25). 
Two possible models to account for NK recognition have 
been suggested (26). These involve either effector inhibition, 
in which a MHC class I molecule provides an inactivating 
signal that blocks the NK cell ability to lyse, or target inter- 
ference, in which an appropriate class I molecule masks a puta- 
tive self-epitope that  is the actual molecular target for NK 
recognition leading to cell lysis.  HLA-C may be one such 
class I molecule, but there is evidence that other class I mole- 
cules may also be involved (27).  The phenotype conferred 
by HLA-Cw*1401 and the HLA-Cw allele  carried on the 
44.2  AH supports  the involvement  of additional  genes. 
Our findings have important  practical implications.  NK 
allorecognition is likely to be involved in bone marrow graft 
rejection in humans given the mouse model and the inade- 
quacy of current matching. We have shown that bone marrow Table  4.  Ancestral Haplotypes Are Associated with Particular NK-defined Haplotypes and Encode NK Specificities that Cannot 
Be Explained by the Putative HLA.Cw Associated Epitope 
NK defined haplotype 
Associated 





-  +  +  7.1  Cw7  S--N* 
8.1  Cw7  S--N 
60.1  Cwl0  ND 
+  +  -  57.1  Cw6  N--K 
18.2  Cw5  N--K 
+  +  +  44.1  Cw5  N--K 
-  ND  ND  60.3  Cw3  S--N 
62.1  Cw3  S--N 
46.1  Cwl  S--N 
18.1  Blank  S--N 
44.2  Blank  S--N* 
+  ND  ND  35.1  Cw4  s  N--K 
35.4  Cw4S  N--K 
13.1  Cw6  N--K 
* Putative epitope defined  by amino acid residues 77-80 on HLA Cw oe chain. 
As determined  in this study. 
$ Based on sequence data submitted to GenBank  by Dr. P. Parham (accession number M84386). 
from  an  HLA-A,B,  DK,DQ  matched,  MLC  nonreactive 
unrelated donor who was mismatched with the recipient for 
the  NK-defined  group  1  specificity  was  rejected  (Witt, 
C. S., F. T. Christiansen, E. Ciccone, R. Herrmann, G. Tay, 
L. Moretta, and K. L. Dawkins, manuscript submitted for 
publication). Also, we have preliminary evidence that mis- 
matching within the/~ block, as shown by mismatching for 
the CL region, is associated  with graft rejection (Tay, G., 
C. S. Witt, F. T. Christiansen, L. Smith, and R. L. Dawkins, 
manuscript submitted for publication). Matching for NK- 
defined aUospecificities is therefore likely to be an important 
factor for successful bone marrow engraftment. Ultimately, 
the relevant target molecules need to be identified and their 
genes mapped and characterized. However, it will not be neces- 
sary to develop direct typing methods for all these NK-defmed 
specificities. Rather, it will only be necessary  to identify a 
marker specific for the MHC blocks associated with each of 
the approximately 40 AH present in each major racial group. 
Matching for these blocks will result in matching for all the 
NK allospecificities present within these blocks. We have data 
that the polymorphic CL region provides such a haplospecific 
marker for the 3 block. Crossmatching donor and recipient 
at CL would therefore match for the NK-defined specificities. 
Work is currently in progress  to confirm the validity of this 
approach. 
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